Mota Rubén A, Hernández-Espinosa David, Galbis-Martinez Lilian, Ordoñez Adriana, Miñano Antonia, Parrilla Pascual, Vicente Vicente, Corral Javier, Yélamos José
Department of Surgery, Hospital Virgen de la Arrixaca, Ciberehd, Murcia, Spain.
Crit Care Med. 2008 Feb;36(2):526-34. doi: 10.1097/01.CCM.0000299735.43699.E9.
Heat stroke is a life-threatening illness characterized by an increased core body temperature as a result of exposure to high ambient temperature. Despite advances in supportive care, heat stroke is often fatal, and no specific and effective therapies exist. The pathophysiological responses to heat stroke involve a systemic inflammatory response and a disseminated intravascular coagulation in the host, which lead to a multiorgan dysfunction syndrome. Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear DNA-binding protein that has been shown to play a relevant role in cell necrosis and organ failure in various diseases associated with inflammation. Therefore, we set out to investigate whether inhibition of PARP activity might affect the heat stroke-induced injury.
Controlled animal study.
Research laboratory of an academic institution.
PARP-1-deficient mice (Parp-1(-/-)) and wild-type mice (C57BL/6J).
Wild-type mice untreated or treated with either PJ34 or 3-AB, two generic PARP inhibitors, and Parp-1(-/-) mice were subjected to heat exposure as a model to study heat stroke.
We measured rectal temperature, serum interleukin-1beta and interleukin-6, liver histology, and heat shock proteins expression. We found that the heat stroke-induced injury was attenuated in mice lacking PARP-1 and was markedly reduced in wild-type mice treated with PARP inhibitors. Interestingly, heat-induced expression of heat shock proteins 27 and 70 was boosted after PARP inhibition. Indeed, PARP inhibition increased expression of heat shock proteins 27 and 70 even in the absence of heat exposure. Accordingly, PARP inhibition increased thermal tolerance that may contribute to attenuate the clinical effects of heat stroke, resulting in increased survival.
Our results find a new protective function of PARP inhibitors and support their potential therapeutic application in the treatment of heat stroke.
中暑是一种危及生命的疾病,其特征是由于暴露于高温环境导致核心体温升高。尽管在支持性治疗方面取得了进展,但中暑往往是致命的,且不存在特异性有效的治疗方法。中暑的病理生理反应涉及宿主的全身炎症反应和弥散性血管内凝血,进而导致多器官功能障碍综合征。聚(ADP - 核糖)聚合酶 -1(PARP -1)是一种核DNA结合蛋白,已被证明在与炎症相关的各种疾病的细胞坏死和器官衰竭中发挥相关作用。因此,我们着手研究抑制PARP活性是否可能影响中暑诱导的损伤。
对照动物研究。
一所学术机构的研究实验室。
PARP -1缺陷小鼠(Parp -1(-/-))和野生型小鼠(C57BL / 6J)。
未处理的野生型小鼠、用两种通用PARP抑制剂PJ34或3 - AB处理的野生型小鼠以及Parp -1(-/-)小鼠接受热暴露作为研究中暑的模型。
我们测量了直肠温度、血清白细胞介素 -1β和白细胞介素 -6、肝脏组织学以及热休克蛋白表达。我们发现,缺乏PARP -1的小鼠中暑诱导的损伤减轻,在用PARP抑制剂处理的野生型小鼠中损伤明显减少。有趣的是,PARP抑制后热诱导的热休克蛋白27和70的表达增强。实际上,即使在没有热暴露的情况下,PARP抑制也增加了热休克蛋白27和70的表达。相应地,PARP抑制增加了热耐受性,这可能有助于减轻中暑产生的临床影响,从而提高生存率。
我们的结果发现了PARP抑制剂的一种新的保护功能,并支持它们在中暑治疗中的潜在治疗应用。